Genetic Association of CDC2 with Cerebrospinal Fluid Tau in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|20|6|367-374

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.20, Iss.6, 2005-11, pp. : 367-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Phospho-Tau, Total Tau and β-Amyloid1–42 in the Differentiation between Alzheimer’s Disease and Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 4, 2002-11 ,pp. : 183-190

Karger

Access to resources Recommend Favorite

Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 5, 2009-05 ,pp. : 474-480

Karger

Access to resources Recommend Favorite

Concentrations of Metals, β-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 1, 2009-08 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Tau Protein Levels and 18F-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 30, Iss. 3, 2010-09 ,pp. : 245-253

Karger

Access to resources Recommend Favorite

The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer’s Disease, Reflecting a Common Pathophysiological Process

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 257-264

Karger

Access to resources Recommend Favorite